These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15281003)

  • 1. In vivo glycated low-density lipoprotein is not more susceptible to oxidation than nonglycated low-density lipoprotein in type 1 diabetes.
    Jenkins AJ; Thorpe SR; Alderson NL; Hermayer KL; Lyons TJ; King LP; Chassereau CN; Klein RL
    Metabolism; 2004 Aug; 53(8):969-76. PubMed ID: 15281003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Vitamin E on susceptibility of low-density lipoprotein and low-density lipoprotein subfractions to oxidation and on protein glycation in NIDDM.
    Reaven PD; Herold DA; Barnett J; Edelman S
    Diabetes Care; 1995 Jun; 18(6):807-16. PubMed ID: 7555507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LDL from patients with well-controlled IDDM is not more susceptible to in vitro oxidation.
    Jenkins AJ; Klein RL; Chassereau CN; Hermayer KL; Lopes-Virella MF
    Diabetes; 1996 Jun; 45(6):762-7. PubMed ID: 8635650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation, characterization, and metabolism of the glycated and nonglycated subfractions of low-density lipoproteins isolated from type I diabetic patients and nondiabetic subjects.
    Klein RL; Laimins M; Lopes-Virella MF
    Diabetes; 1995 Sep; 44(9):1093-8. PubMed ID: 7657034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is glycation of low density lipoproteins in patients with Type 2 diabetes mellitus a LDL pre-oxidative condition?
    Moro E; Alessandrini P; Zambon C; Pianetti S; Pais M; Cazzolato G; Bon GB
    Diabet Med; 1999 Aug; 16(8):663-9. PubMed ID: 10477211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of glycemic optimization on electronegative low-density lipoprotein in diabetes: relation to nonenzymatic glycosylation and oxidative modification.
    Sánchez-Quesada JL; Pérez A; Caixàs A; Rigla M; Payés A; Benítez S; Ordóñez-Llanos J
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3243-9. PubMed ID: 11443196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidant content in low density lipoprotein and lipoprotein oxidation in vivo and in vitro.
    Tertov VV; Sobenin IA; Kaplun VV; Orekhov AN
    Free Radic Res; 1998 Aug; 29(2):165-73. PubMed ID: 9790519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of low- and high-density lipoproteins from diabetic subjects to in vitro oxidative modification.
    Julier K; Mackness MI; Dean JD; Durrington PN
    Diabet Med; 1999 May; 16(5):415-23. PubMed ID: 10342342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperketonemia (acetoacetate) increases the oxidizability of LDL + VLDL in Type-I diabetic patients.
    Jain SK; McVie R; Jaramillo JJ; Chen Y
    Free Radic Biol Med; 1998 Jan; 24(1):175-81. PubMed ID: 9436628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RRR-alpha-tocopheryl acetate supplementation at pharmacologic doses decreases low-density-lipoprotein oxidative susceptibility but not protein glycation in patients with diabetes mellitus.
    Fuller CJ; Chandalia M; Garg A; Grundy SM; Jialal I
    Am J Clin Nutr; 1996 May; 63(5):753-9. PubMed ID: 8615360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced susceptibility of low-density lipoprotein to in vitro oxidation in type 1 and type 2 diabetic patients.
    Beaudeux JL; Guillausseau PJ; Peynet J; Flourie F; Assayag M; Tielmans D; Warnet A; Rousselet F
    Clin Chim Acta; 1995 Aug; 239(2):131-41. PubMed ID: 8542651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electronegative low density lipoprotein subform is increased in patients with short-duration IDDM and is closely related to glycaemic control.
    Sánchez-Quesada JL; Pérez A; Caixàs A; Ordónmez-Llanos J; Carreras G; Payés A; González-Sastre F; de Leiva A
    Diabetologia; 1996 Dec; 39(12):1469-76. PubMed ID: 8960828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycation does not alter LDL-induced secretion of tissue plasminogen activator and plasminogen activator inhibitor-1 from human aortic endothelial cells.
    Klein RL; Semler AJ; Baynes JW; Thorpe SR; Lyons TJ; Jenkins AJ
    Ann N Y Acad Sci; 2005 Jun; 1043():379-89. PubMed ID: 16037259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia.
    Karabina SA; Elisaf M; Bairaktari E; Tzallas C; Siamopoulos KC; Tselepis AD
    Eur J Clin Invest; 1997 Jul; 27(7):595-602. PubMed ID: 9263748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of concentrations of glycated hemoglobin, alpha-tocopherol, copper, and manganese on oxidation of low-density lipoproteins in patients with type I diabetes, type II diabetes and control subjects.
    Leonhardt W; Hanefeld M; Müller G; Hora C; Meissner D; Lattke P; Paetzold A; Jaross W; Schroeder HE
    Clin Chim Acta; 1996 Oct; 254(2):173-86. PubMed ID: 8896905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of low density lipoprotein (LDL) subfraction profile and LDL oxidation on endothelium-dependent and independent vasodilation in patients with type 2 diabetes.
    Tan KC; Ai VH; Chow WS; Chau MT; Leong L; Lam KS
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3212-6. PubMed ID: 10487689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of glycation/glycoxidation on the liberation of 8-epi-PGF2alpha from low density lipoprotein during its in vitro oxidation.
    Sobal G; Menzel EJ; Sinzinger H
    Prostaglandins Leukot Essent Fatty Acids; 2000 Apr; 62(4):217-24. PubMed ID: 10882185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why is glycated LDL more sensitive to oxidation than native LDL? A comparative study.
    Sobal G; Menzel J; Sinzinger H
    Prostaglandins Leukot Essent Fatty Acids; 2000 Oct; 63(4):177-86. PubMed ID: 11049692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative susceptibility of low density lipoprotein subfractions is related to their ubiquinol-10 and alpha-tocopherol content.
    Tribble DL; van den Berg JJ; Motchnik PA; Ames BN; Lewis DM; Chait A; Krauss RM
    Proc Natl Acad Sci U S A; 1994 Feb; 91(3):1183-7. PubMed ID: 8302851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of concentrated n-3 fatty acids versus gemfibrozil on plasma lipoproteins, low density lipoprotein heterogeneity and oxidizability in patients with hypertriglyceridemia.
    Stalenhoef AF; de Graaf J; Wittekoek ME; Bredie SJ; Demacker PN; Kastelein JJ
    Atherosclerosis; 2000 Nov; 153(1):129-38. PubMed ID: 11058707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.